[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P13 SC (Zymfentra) in the U.S. (Rheumatoid Arthritis) / 2024-06-19
[Disclosure] Hana Micron (067310) – Determination of 1st Preliminary Issue Price for Capital Increase / 2024-06-18
[Disclosure] Hana Micron (067310) – (Correction) Decision on Capital Increase with and without Consideration / 2024-06-18